Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine/Triamcinolone Injection for Odynophonia
NCT05178485Phase 4Withdrawn
- Sponsor
- UT Southwestern Medical Center
- Start
- Jul 2023
- Primary completion
- Dec 2024
- Modality
- Orthosteric Ligands
01
Overview
A Phase 4 trial of triamcinolone acetonide, bupivacaine, sponsored by UT Southwestern Medical Center. Planned start Jul 2023; status: withdrawn.
02
Drugs
triamcinolone acetonidebupivacaine
Beyond the preview
Go deeper on NCT05178485.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05178485.